Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-04-24

Clinical Trial Update: Intravesical Instillation of Hyaluronic Acid to Decrease Incidence of Urinary Tract Infection [Phase 4]

View source ↗

Summary

Phase 4 trial on intravesical hyaluronic acid for reducing urinary tract infections was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyaluronic acid intravesical instillation (hyaluronic acid)

Snippet

Sponsor: Rabin Medical Center | Conditions: Urinary Tract Infection | Phase 4 | Status: WITHDRAWN